Fundraise / allotmentFiled on BSE ·

NATCO Pharma Limited files Letter of Offer for Rights Issue closing Oct 22, 2026

Natco Pharma · Pharmaceuticals & Biotechnology

What the filing says

  • Issue Price set at ₹375 per Equity Share, fully paid-up shares with no convertible securities
  • Key promoters hold significant shares: Venkaiah Chowdary Nannapaneni 15.66%, Time Cap Pharma Labs 9.59%
  • All directors and CFO certify compliance with Companies Act, SEBI Act, and disclose true information as of Sept 28, 2026

Original filing

Board Meeting Outcome for Outcome Of Fund Raising Committee Meeting Approving The Letter Of Offer For Rights Issue

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies

Electrical Equipment

Revenue: Rank 1Margin: Rank 1

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Natco Pharma

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.